Latest / Decera Clinical Education Oncology Podcast
Optimizing Anti-CD38–Based Treatment for Smoldering and Newly Diagnosed Multiple Myeloma: Pharmacist Perspectives
In this podcast episode, James A. Davis, PharmD, BCOP, and Kelley L. Julian, PharmD, BCOP, discuss evidence-based strategies for managing smoldering and newly diagnosed multiple myeloma, including:
Risk stratification and treatment selection for smoldering multiple myeloma
Anti-CD38–based regimens for transplant-eligible and transplant-ineligible patients
Clinical evidence supporting triplet and quadruplet therapies
MRD assessment and response-adapted treatment strategies
Frailty, transplant eligibility, and individualized treatment selection
Subcutaneous anti-CD38 administration and…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.